About AmpliPhi Biosciences Corp.
Develops and commercializes novel bacteriophage-based therapeutics
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.55$ per share.
The book value per share is 0.51$
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|